These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7577844)

  • 21. 5-HT3 receptor antagonists attenuate cocaine-induced locomotion in mice.
    Reith ME
    Eur J Pharmacol; 1990 Sep; 186(2-3):327-30. PubMed ID: 2289534
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Possible involvement of 5-HT4 receptors, in addition to 5-HT3 receptors, in the emesis induced by high-dose cisplatin in Suncus murinus.
    Horikoshi K; Yokoyama T; Kishibayashi N; Ohmori K; Ishii A; Karasawa A
    Jpn J Pharmacol; 2001 Jan; 85(1):70-4. PubMed ID: 11243577
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phenylimidazolidin-2-one derivatives as selective 5-HT3 receptor antagonists and refinement of the pharmacophore model for 5-HT3 receptor binding.
    Heidempergher F; Pillan A; Pinciroli V; Vaghi F; Arrigoni C; Bolis G; Caccia C; Dho L; McArthur R; Varasi M
    J Med Chem; 1997 Oct; 40(21):3369-80. PubMed ID: 9341912
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Profile of action of 5-HT3 receptor antagonists, ondansetron and WAY 100289, in the elevated plus-maze test of anxiety of mice.
    Rodgers RJ; Cole JC; Tredwell JM
    Psychopharmacology (Berl); 1995 Feb; 117(3):306-12. PubMed ID: 7770606
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Profiles of interaction of R(+)/S(-)-zacopride and anxiolytic agents in a mouse model.
    Barnes NM; Cheng CH; Costall B; Ge J; Kelly ME; Naylor RJ
    Eur J Pharmacol; 1992 Jul; 218(1):91-100. PubMed ID: 1356807
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of 5-HT3 receptor antagonists on gastrointestinal motility].
    Yoshida N; Ito T; Karasawa T; Iwanaga H; Mizumoto A; Ito A
    Nihon Heikatsukin Gakkai Zasshi; 1989 Dec; 25(6):315-9. PubMed ID: 2562028
    [No Abstract]   [Full Text] [Related]  

  • 27. Characterization of a novel 5-HT4 receptor antagonist of the azabicycloalkyl benzimidazolone class: DAU 6285.
    Dumuis A; Gozlan H; Sebben M; Ansanay H; Rizzi CA; Turconi M; Monferini E; Giraldo E; Schiantarelli P; Ladinsky H
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Mar; 345(3):264-9. PubMed ID: 1320204
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 5-HT3 receptor antagonists for the prevention of chemotherapy-induced nausea and vomiting. A comparison of their pharmacology and clinical efficacy.
    Gregory RE; Ettinger DS
    Drugs; 1998 Feb; 55(2):173-89. PubMed ID: 9506240
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel 5-HT3 antagonists. Indole oxadiazoles.
    Swain CJ; Baker R; Kneen C; Moseley J; Saunders J; Seward EM; Stevenson G; Beer M; Stanton J; Watling K
    J Med Chem; 1991 Jan; 34(1):140-51. PubMed ID: 1992112
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stimulant effects of 5-hydroxytryptamine on guinea pig stomach preparations in vitro.
    Buchheit KH; Buhl T
    Eur J Pharmacol; 1994 Sep; 262(1-2):91-7. PubMed ID: 7813582
    [TBL] [Abstract][Full Text] [Related]  

  • 31. BRL 46470A: a highly potent, selective and long acting 5-HT3 receptor antagonist with anxiolytic-like properties.
    Blackburn TP; Baxter GS; Kennett GA; King FD; Piper DC; Sanger GJ; Thomas DR; Upton N; Wood MD
    Psychopharmacology (Berl); 1993; 110(3):257-64. PubMed ID: 7831418
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 5-HT3 receptor antagonists. 2. 4-Hydroxy-3-quinolinecarboxylic acid derivatives.
    Hayashi H; Miwa Y; Ichikawa S; Yoda N; Miki I; Ishii A; Kono M; Yasuzawa T; Suzuki F
    J Med Chem; 1993 Mar; 36(5):617-26. PubMed ID: 8496941
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 5-HT3 receptor antagonists reverse helpless behaviour in rats.
    Martin P; Gozlan H; Puech AJ
    Eur J Pharmacol; 1992 Feb; 212(1):73-8. PubMed ID: 1532555
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The enantiomers of zacopride: an intra-species comparison of their potencies in functional and anxiolytic models.
    Bill DJ; Coleman J; Hallett I; Middlefell VC; Rhodes KF; Fletcher A
    Br J Pharmacol; 1995 Jul; 115(5):775-80. PubMed ID: 8548176
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of high-affinity 5-HT3 receptor antagonists. Structure-affinity relationships of novel 1,7-annelated indole derivatives.
    van Wijngaarden I; Hamminga D; van Hes R; Standaar PJ; Tipker J; Tulp MT; Mol F; Olivier B; de Jonge A
    J Med Chem; 1993 Nov; 36(23):3693-9. PubMed ID: 8246239
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and biological evaluation of novel gamma-carboline analogues of Dimebon as potent 5-HT6 receptor antagonists.
    Ivachtchenko AV; Frolov EB; Mitkin OD; Kysil VM; Khvat AV; Okun IM; Tkachenko SE
    Bioorg Med Chem Lett; 2009 Jun; 19(12):3183-7. PubMed ID: 19443217
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GYKI-46 903, a non-competitive antagonist for 5-HT3 receptors.
    Csillik-Perczel V; Bakonyi A; Yemane T; Vitalis B; Horvath E; Solyom S; Szekely JI; Harsing LG
    Pharmacol Toxicol; 1996 Jul; 79(1):32-9. PubMed ID: 8841094
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correction: chemical structures of serotonin and serotonin-receptor antagonists.
    Holder EP
    Ann Pharmacother; 1996 Sep; 30(9):1043. PubMed ID: 8876880
    [No Abstract]   [Full Text] [Related]  

  • 39. Different effects of tropisetron and ondansetron in learning and memory paradigms.
    Pitsikas N; Borsini F
    Pharmacol Biochem Behav; 1997 Apr; 56(4):571-6. PubMed ID: 9130279
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the 5-HT3 receptor antagonist properties of ICS 205-930, GR38032F and zacopride.
    Cohen ML; Bloomquist W; Gidda JS; Lacefield W
    J Pharmacol Exp Ther; 1989 Jan; 248(1):197-201. PubMed ID: 2521513
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.